Brompton Global Healthcare Income & Growth ETF (TSX: HIG)
Canada
· Delayed Price · Currency is CAD 8.53
0.00 (-0.06%)
Jul 2, 2024, 3:59 PM EDT
0.41% (1Y)
| Assets | 52.42M |
| Expense Ratio | 1.09% |
| PE Ratio | 30.75 |
| Dividend (ttm) | 0.66 |
| Dividend Yield | 7.74% |
| Ex-Dividend Date | Jun 28, 2024 |
| Payout Frequency | Monthly |
| Payout Ratio | 231.97% |
| 1-Year Return | +2.11% |
| Volume | 10 |
| Open | 8.56 |
| Previous Close | 8.53 |
| Day's Range | n/a |
| 52-Week Low | 7.65 |
| 52-Week High | 8.90 |
| Beta | 0.93 |
| Holdings | 26 |
| Inception Date | Apr 3, 2018 |
About HIG
Brompton Global Healthcare Income & Growth ETF (HIG) is an exchange-traded fund that trades on the Toronto Stock Exchange in Canada. It is an actively managed fund that invests in global large-cap health care companies, overlaid by a covered call options.
Asset Class Equity
Category Health Care
Stock Exchange Toronto Stock Exchange
Ticker Symbol HIG
Provider Brompton
Performance
HIG had a total return of 2.11% in the past year. Since the fund's inception, the average annual return has been -1.25%, including dividends.
Top 10 Holdings
49.23% of assets| Name | Symbol | Weight |
|---|---|---|
| Merck & Co., Inc. | MRK | 5.45% |
| AstraZeneca PLC | AZN | 5.38% |
| Cencora | COR | 5.38% |
| Eli Lilly and Company | LLY | 5.04% |
| McKesson Corporation | MCK | 4.85% |
| Novo Nordisk A/S | NVO | 4.70% |
| HCA Healthcare, Inc. | HCA | 4.63% |
| Boston Scientific Corporation | BSX | 4.63% |
| Stryker Corporation | SYK | 4.61% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.55% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 28, 2024 | 0.055 CAD | Jul 15, 2024 |
| May 31, 2024 | 0.055 CAD | Jun 14, 2024 |
| Apr 29, 2024 | 0.055 CAD | May 14, 2024 |
| Mar 27, 2024 | 0.055 CAD | Apr 12, 2024 |
| Feb 28, 2024 | 0.055 CAD | Mar 14, 2024 |
| Jan 30, 2024 | 0.055 CAD | Feb 14, 2024 |